Figure 1.
Kaplan-Meier survival curves of patients treated with weekly albumin-bound paclitaxel (Abraxane®) over 2-hours versus 30-minutes.
Kaplan-Meier survival curves of patients treated with weekly albumin-bound paclitaxel (Abraxane®) over 2-hours versus 30-minutes.